8-bromo-1-octanethiol | 202824-07-5

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醇
• 英文名称: 8-bromo-1-octanethiol
• 英文别名: 8-bromooctane-1-thiol
• CAS: 202824-07-5
• 化学式: C₈H₁₇BrS
• 分子量: 225.193
• InChiKey: HRJRKWIXCKJRIM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  10
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  8-bromo-1-octanethiol 在 碘 作用下， 以 乙醇 为溶剂， 以80%的产率得到di(8-bromooctyl)disulfide
  参考文献：
  名称：

  Cleavable, water-soluble surfactants

  摘要：

  本发明提供了一种新型水溶性可断裂表面活性剂的类别和利用这些表面活性剂的方法。

  公开号：

  US06600076B1
• 作为产物：
  描述：

  8-(acetylthio)octyl bromide 在 盐酸 作用下， 以 甲醇 为溶剂， 以75%的产率得到(8-mercaptooctyl)trimethylammonium bromide
  参考文献：
  名称：

  Cleavable, water-soluble surfactants

  摘要：

  本发明提供了一种新型水溶性可断裂表面活性剂的类别和利用这些表面活性剂的方法。

  公开号：

  US06600076B1

文献信息

• 3-HETEROARYLSUBSTITUIERTE 5-METHYLOXYMETHYL-ISOXAZOLINE ALS HERBIZIDE
  申请人：BASF SE

  公开号：EP1501361B1

  公开（公告）日：2009-09-30
• WATER-SOLUBLE NANOCRYSTALS AND METHODS OF PREPARING THEM
  申请人：Agency for Science, Technology and Research

  公开号：EP1848995A1

  公开（公告）日：2007-10-31
• 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
  申请人：Wagner Oliver

  公开号：US20050165020A1

  公开（公告）日：2005-07-28

  3-Heteroaryl-substituted isoxazolines of the formula I where: X is substituted 5-membered heteroaryl having one to four nitrogen atoms or one to three nitrogen atoms and one oxygen or sulfur atom or one oxygen or sulfur atom; or substituted 6-membered heteroaryl having one to four nitrogen atoms; where the abovementioned 5-membered heteroaryl is not pyrazolyl or thienyl; R 1 -R 7 are hydrogen, alkyl or haloalkyl; Y is unsubstituted or substituted aryl, or benzo[1,4]dioxonyl, benzo[1,3]dioxolanyl, 2,3-dihydrobenzofuranyl or benzimidazole; or unsubstituted or substituted 5- to 6-membered heteroaryl; and their agriculturally useful salts, processes and intermediates for their preparation, and the use of these compounds or of the compositions comprising these compounds for controlling unwanted plants are described.
• DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS
  申请人：Agrawal C. Mauli

  公开号：US20090123516A1

  公开（公告）日：2009-05-14

  Disclosed are medical devices comprising one or more surfaces, one or more SAM molecules attached to the one or more surfaces of the medical device, and one or more therapeutic agents attached to the one or more self-assembled monolayer molecules. Also disclosed are medical devices comprising one or more surfaces, one or more self-assembled monolayer molecules attached to the one or more surfaces of the medical device, one or more linkers comprising a first functional group and a second functional group, the first functional group attached to the self-assembled monolayer molecule and a therapeutic agent attached to the second functional group. The therapeutic agent may be attached to the SAM molecule via a linker. The present invention also concerns methods of administering a therapeutic agent to a subject, comprising contacting the subject with one of the medical devices set forth herein.
• US6284365B1
  申请人：——

  公开号：US6284365B1

  公开（公告）日：2001-09-04